Physician profile
Tinbit S Abebe
NPI 1669993762
$1,643.71
in general payments reported to CMS, 2019-2025
14 companies · $463 in 2025
The $463 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.11 · 2022: $12.16 · 2023: $259 · 2024: $885 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,607.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $624.26 | 2023-2025 | Lifevest |
| Medtronic, INC. | $510.77 | 2023-2025 | Symplicity G3, Micra, Onyx Frontier |
| Inari Medical, INC. | $103.05 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $75.39 | 2024-2025 | |
| Cvrx, INC. | $67.53 | 2024-2025 | Barostim Neo System |
| Abbott Laboratories | $50.74 | 2024-2025 | Diamondback Coronary |
| Biotronik INC. | $47.51 | 2025 | Acticor 7 Vr-T Dx |
| Janssen Pharmaceuticals, INC | $43.74 | 2021-2024 | Xarelto |
| Lantheus Medical Imaging, INC. | $33.75 | 2025 | |
| Cardiva Medical, INC. | $24.99 | 2024 | Optowire |
| Boston Scientific Corporation | $19.01 | 2023 | Interlock |
| Teleflex LLC | $17.48 | 2023 | Vascband |
| Kestra Medical Technology Services, INC. | $13.33 | 2023 | Assure Wcd |
| Shockwave Medical, INC | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tinbit Abebe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.